Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

Healthcare Drug Manufacturers - Specialty & Generic
"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

MERUS LABS INTERNATIONAL INC > Peter Imhof on BNN today
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6203)
•••
Comment by retiredcfon Feb 24, 2015 8:17am
199 Views
Post# 23458090

RE:Peter Imhof on BNN today

RE:Peter Imhof on BNN todaySecond stock in the clip (at the end of his discussion on Biosyent). GLTA

https://www.bnn.ca/Video/player.aspx?vid=557015

2015-02-23 BUY Peter Imhof

Likes the story but the valuation is a bit too high. It is not that liquid of a stock. Hard to buy in a fund, but okay for individual investors. Prefers MSL-T.

 Price:
$10.010
Subject:
NORTH AMERICAN - SMALL
Bias:
BULLISH on SMALL CAPS
Owned:
Unknown

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities